Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telbivudine with Tenofovir Intensification in HBeAg-positive CHB
NCT00651209Phase 4Completed
- Sponsor
- Novartis
- Start
- Feb 2008
- Primary completion
- Dec 2011
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 4
01
Overview
A Phase 4 trial of telbivudine in Chronic Hepatitis B (CHB), sponsored by Novartis. Started Feb 2008; status: completed.
02
Drugs
telbivudine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00651209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00651209.